| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 48,114 | 47,205 | 47,975 | 48,008 | | Cost of Revenue | 24,044 | 2,287 | 6,408 | 56,203 | | | Gross Profit | 24,070 | 44,918 | 41,567 | (8,195) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 16,517 | 37,884 | 34,028 | (14,603) | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 3,334 | 3,275 | 3,253 | 3,766 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 4,219 | 3,759 | 4,286 | 2,642 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 4 | 20 | 91 | 53 | | Earnings Before Interest And Taxes | 4,223 | 3,779 | 4,377 | 2,695 | | Interest Expense | 2,967 | 2,956 | 2,948 | 3,045 | | Income Before Tax | 1,256 | 823 | 1,429 | (350) | | Income Tax Expense | 506 | 394 | 609 | (136) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 750 | 429 | 820 | (214) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 750 | 429 | 820 | (214) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $750 | $429 | $820 | ($214) |
|
0.51% Nasdaq 
Income Statement
